Grifols (GRFS) P/S (2011 - 2026)
Grifols (GRFS) P/S from Jun 2, 2011 to Jun 3, 2026. The TTM Grifols (GRFS) P/S is 0.58. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Grifols (GRFS)
| Year | P/S | Change |
|---|---|---|
| 2026 | 0.58 | -20.70% |
| 2025 | 0.74 | +12.42% |
| 2024 | 0.65 | -41.75% |
| 2023 | 1.12 | -13.58% |
| 2022 | 1.30 | -25.36% |
| 2021 | 1.74 | -6.86% |
| 2020 | 1.87 | -31.27% |
| 2019 | 2.72 | +13.91% |
| 2018 | 2.39 | -26.80% |
| 2017 | 3.26 | +34.51% |
| 2016 | 2.42 | -5.43% |
| 2015 | 2.56 | -4.79% |
| 2014 | 2.69 | -19.38% |
| 2013 | 3.34 | +30.91% |
| 2012 | 2.55 | +51.46% |
| 2011 | 1.68 | N/A |
Comparison Grifols (GRFS) P/S with competitors
Grifols (GRFS) P/S is 0.58.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -2.41% |
| NVO | Novo Nordisk | 0.60 | +3.25% |
| AMRN | Amarin Corp | 1.38 | +137.20% |
| SCLX | Scilex Holding Company | 1.50 | +156.92% |
| SNY | Sanofi | 2.24 | +284.52% |
| PFE | Pfizer Inc | 2.36 | +304.59% |
| BMY | Bristol-Myers Squibb Company | 2.42 | +315.57% |
| BIIB | Biogen Inc | 2.91 | +399.43% |
| GSK | GSK Plc | 3.16 | +441.28% |
| MRK | Merck & Co Inc | 4.51 | +674.36% |
| AZN | Astrazeneca plc | 4.75 | +715.52% |
| AMGN | AMGEN Inc | 4.87 | +735.76% |
| NVS | Novartis AG | 5.10 | +774.70% |
| GILD | Gilead Sciences Inc | 5.58 | +857.02% |
| JNJ | Johnson & Johnson | 5.78 | +891.32% |
| ABBV | Abbvie Inc | 6.06 | +939.34% |
| LLY | Lilly(Eli) & Company | 13.37 | +2193.07% |